Bionano Genomics effects 1-for-60 reverse stock split effective Jan 24, 2025

Bionano Genomics, Inc.

Reverse stock split at ratio 1:60, effective 5:00 p.m. ET on January 24, 2025.
Common stock begins trading split-adjusted on Nasdaq Capital Market under BNGO on Jan 27.
No fractional shares issued; stockholders entitled to fractional shares receive cash in lieu.
Proportionate adjustments to stock options, RSUs, warrants, and convertible debentures exercise prices and share counts.
New CUSIP number for common stock post-split: 09075F404.

item 3.03 item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Bionano Genomics, Inc.: Filed Certificate of Amendment to effect a 1-for-60 reverse stock split (effective 2025-01-24).

Change: charter amendment
Effective: 2025-01-24

Exact text from the filing

On January 24, 2025, Bionano Genomics, Inc. (the “ Company ”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “ Restated Certificate ”), with the office of the Secretary of State of the State of Delaware to effect a reverse stock split at a ratio of 1:60 (the “ Charter Amendment ”).

View on SEC.gov

29 governance changes filed in the last 30 days. Browse all governance changes →

Bionano Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001411690-25-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.